Molecular predictors for the response to nilotinib treatment after acquired imatinib failure in ph+ chronic myeloid leukemia
journal contribution
posted on 2010-11-01, 00:00authored byM Agrawal, P Erben, B Hanfstein, A Leitner, John Reynolds, R Woodman, L Robin, W K Hofmann, A Hochhaus, M Muller
Molecular predictors for the response to nilotinib treatment after acquired imatinib failure in ph+ chronic myeloid leukemia
History
Journal
Blood
Volume
116
Issue
21
Season
Abstract 2283
Pagination
1 - 1
Publisher
American Society of Hematology
Location
Washington, D. C.
ISSN
0006-4971
eISSN
1528-0020
Language
eng
Notes
Alternative source title : Blood (ASH Annual Meeting Abstracts); Chronic Myeloid Leukemia - Therapy Poster II presented at American Society of Hematology. Annual Meeting (52nd : 2010 : Orlando, Florida) held from 4 - 7 Dec. 2010